Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen

Endocrinology

Volumn 144, Issue 10, 2003, Pages 4403-4409

  Gómez, Oscar ^a   Balsa, José Antonio ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DIETHYLSTILBESTROL; ESTROGEN; MESSENGER RNA; NEUROPEPTIDE; PROLACTIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BRAIN CORTEX; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HYPERPLASIA; HYPOPHYSIS; HYPOTHALAMUS; IMPLANTATION; NONHUMAN; ORGAN WEIGHT; PARACRINE SIGNALING; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; RNA ANALYSIS;

ANIMALS; AUTOCRINE COMMUNICATION; CEREBRAL CORTEX; DIETHYLSTILBESTROL; ENDOTHELIAL GROWTH FACTORS; ESTROGENS, NON-STEROIDAL; FEMALE; HYPERPLASIA; HYPOTHALAMUS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; ORGAN SIZE; PARACRINE COMMUNICATION; PITUITARY GLAND; PITUITARY GLAND, ANTERIOR; PROLACTIN; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0141450585     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0261     Document Type: Article

References (55)

1. Meyer RK, Clifton KH 1956 Effect of diethylstilbestrol-induced tumorigenesis on the secretory activity of the rat anterior pituitary gland. Endocrinology 58:686-690
2. Morgan WW, Steger RW, Smith MS, Bartke A, Sweeney CA 1985 Time course of induction of PRL-secreting pituitary tumors with diethylstilbestrol in male rats. Response of tuberoinfundibular dopaminergic neurons. Endocrinology 116:17-24
3. Lloyd RV 1983 Estrogen induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. Am J Pathol 113:198-206
4. Sarkar DK, Kim KH, Minami S 1992 Transforming growth factor-β1 mRNA and protein expression in the pituitary gland and its action on PRL-secretion and lactotropic growth. Mol Endocrinol 6:1825-1833
5. Hentges S, Boyadjieva N, Sarkar DK 2001 Effect of antisense suppression of transforming growth factor-β3 gene on lactotropic cell proliferation. J Neuroendocrinol 13:324-327
6. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S 1999 Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5:1317-1321
7. Wynick D, Hammond PJ, Akinsanya KO, Bloom SR 1993 galanin regulates basal and oestrogen-stimulated lactotroph function. Nature 364:529-532
8. Cai A, Bowers RC, Moore JP, Hyde JF 1998 Function of galanin in the anterior pituitary of estrogen-treated Fisher 344 rats: autocrine and paracrine regulation of prolactin secretion. Endocrinology 139:2452-2458
9. Sarkar DK, Gottschall PE, Meites J 1982 Damage to hypothalamic dopaminergic neurons is associated with development of prolactin secreting tumors. Science 218:684-686
10. El-Azouzi M, Hsu DWW, Black P, Jolesz F, Hedley-Whyte T, Klibanski A, Zervas NT 1990 The importance of dopamine in the pathogenesis of experimental prolactinomas. J Neurosurg 72:273-281
11. Robbercht P, Deschodt-Lanckman M, Camus JC, de-Neef P, Lambert M, Christophe J 1979 VIP activation of rat anterior pituitary adenylate cyclase. FEBS Lett 103:229-233
12. Mezey E, Kiss JZ 1985 Vasoactive intestinal polypeptide-containing neurons in the paraventricular nucleus may participate in regulating prolactin secretion. Proc Natl Acad Sci USA 82:245-247
13. Hagen TC, Arnaout MA, Scherzer WJ, Martinson DR, Garthwaite TL 1986 Antisera to vasoactive intestinal polypeptide inhibit basal prolactin release from dispersed anterior pituitary cells. Neuroendocrinology 43:641-645
14. Nagy G, Mulchahey JJ, Neill JD 1988 Autocrine control of prolactin secretion by vasoactive intestinal peptide. Endocrinology 122:364-366
15. Lara JI, Lorenzo MJ, Cacicedo L, Tolón R, Balsa JA, López-Fernández J, Sánchez-Franco F 1994 Induction of vasoactive intestinal peptide (VIP) gene expression and prolactin (PRL) secretion by insulin-like growth factor-I (IGF-I) in rat pituitary cells: evidence for an autoparacrine regulatory system. Endocrinology 135:2526-2532
16. Balsa JA, Cacicedo L, Lara JI, Lorenzo MJ, Pazos F, Sá nchez-Franco F 1996 Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone-induced prolactin release. Endocrinology 137:144-150
17. Balsa JA, Sánchez-Franco F, Lorenzo MJ, Pazos F, Lara JI, Cacicedo L 1996 Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of PRL secretion. Endocrinology 137:508-513
18. Balsa JA, Sánchez-Franco F, Pazos F, Lara JI, Lorenzo MJ, Maldonado G, Cacicedo L 1998 Direct action of serotonin on prolactin, growth hormone, ACTH and luteinizing hormone release in cocultures of anterior and posteriorpituitary lobes: autocrine and/or paracrine action of vasoactive intestinal peptide Neuroendocrinology 68:326-333
19. Kasper S, Popescu RA, Torsello A, Vrontakis ME, Ikejiani C, Friesen HG 1992 Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by estrogen in the rat. Endocrinology 130:1796-1801
20. Lam KSL, Srivastava G, Lechan RM, Lee T, Reichlin S 1990 Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary. Neuroendocrinology 52:417-421
21. Prysor-Jones RA, Silverlight JJ, Kennedy SJ, Jenkins JS 1988 Vasoactive intestinal peptide and the stimulation of lactotroph growh by oestradiol in rats. J Endocrinol 116:259-265
22. Jakubowski J 1995 Blood supply, blood flow and autoregulation in the adenohypophysis, and altered patterns in oestrogen induced adenomatous hyperplasia. Br J Neurosurg 9:331-346
23. Stepien H, Grochal M, Zielinski KW, Mucha S, Kunert-Radek J, Kulig A, Stawowy A, Pisarek H 1996 Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen induced prolactinoma in Fisher 344 rats. J Endocrinol 150:99-106
24. Ferrara N 2000 Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55:15-35
25. Banerjee SK, Zoubine NN, Tran TM, Weston AP, Campbell DR 2000 Overexpression of vascular endothelial growth factor 164 and its co-receptor neuropilin-1 in estrogen induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 16:253-260
26. 17] VIP. Am J Physiol 250:G553-557
27. Bradford MM 1976 A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 7:72248-72254
28. Chomczynski P, Sacchi N 1987 Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 162:156-159
29. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM, Stillman B 1987 Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein. Nature 326:517-520
30. Dawson AE, Norton JA, Weinberg DS 1990 Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 136:1115-1124
31. Wijsman JH, Van Dierendonck JH, Keijzer R, van de Velde CJ, Cornelisse CJ 1992 Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue. J Pathol 168:75-83
32. Perentes E, Arnold J, Meier G, Ettlin RA, Karamitopoulou E, Prentice DE 1994 Proliferating cell nuclear antigen expression in Wistar rat livers. A retrospective immunohistochemical study of normal and neoplastic livers. Exp Toxicol Pathol 46:105-110
33. Goda H, Sakai T, Kurosumi M, Inoue K 1998 Prolactin-producing cells differentiate from G0/G1-arrested somatotrophs in vitro: an analysis of cell cycle phases and mammotroph differentiation. Endocr J 45:725-735
34. Asa SL, Ramyar L, Murphy PR, Li AW, Ezzat S 2001 The endogenous fibroblast growth factor-2 antisense gene product regulates pituitary cell growth and hormone production. Mol Endocrinol 15:589-599
35. Banerjee SK, De A, Sarkar DK 1994 Colocalization of prolactin and proliferating cell nuclear antigen in the anterior pituitary during estrogen-induced pituitary tumors. Cancer Lett 87:139-144
36. Sergenson TP, Lam KSL, Cacicedo L, Minamitami N, Fink JS, Lechan RM, Reichlin S 1989 Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland. Endocrinology 125:2221-2223
37. Jones PM, Ghatei MA, Steele J, O'Halloran D, Gon G, Legon S, Burrin JM, Leonhardt U, Polak JM, Bloom S R 1989 Evidence for neuropeptide Y synthesis in the rat anterior pituitary and the influence of thyroid hormone status: comparison with vasoactive intestinal peptide, substance P, and neurotensin. Endocrinology 125:334-341
38. Koves K, Gottschall PE, Gorcs T, Scammell JG, Arimura A 1990 Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscopic immunohistochemical study. Endocrinology 126:1756-1763
39. Chew LJ, Seah V, Murphy D, Carter D 1996 Anterior pituitary vasoactive intestinal peptide mRNA is colocalised with prolactin mRNA in hyperoestrogenised rats. J Mol Endocrinol 16:211-220
40. Moody TW, Hill JM, Jensen RT 2003 VLP as atrophic factor in the CNS and cancer cells. Peptides 24:163-177
41. Suzuki S, Yamamoto Y, Arita J 1999 Mitogen activated protein kinase dependent stimulation of proliferation of rat lactotroph in culture by 3′5′-cyclic adenosine monophosphate. Endocrinology 140:2850-2858
42. Fernández M, Sánchez-Franco F, Palacios N, Sánchez I, Villuendas G, Cacicedo L 2003 Involvement of vasoactive intestinal peptide on insulin-like growth factor I-induced proliferation of rat pituitary lactotropes in primary culture: evidence for an autocrine and/or paracrine regulatory system. Neuroendocrinology 77:341-352
43. Maas DL, Martinson DR, Erdmann MD, Wahle JS, Hagen TC 1995 Dynamics of prolactin secretion from diethylstilbestrol-induced rat prolactinoma tissue in vitro. Proc Soc Exp Biol Med 210:150-155
44. Dickson RB, Lippman ME 1987 Estrogenic regulation of growth factors and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 8:29-43
45. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB 1987 Evidence that transforming growth factor β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428
46. Soto AM, Sonnenschein C 1987 Cell proliferation of estrogen sensitive cells: the case for negative control. Endocr Rev 8:417-428
47. Pastorcic M, De A, Boyadjieva N, Vale W, Sarkar DK 1995 Reduction in the expression and action of transforming growth factor β 1 on lactotropes during estrogen induced tumorigenesis in the anterior pituitary. Cancer Res 55:4892-4898
48. Minami S, Sarkar DK 1997 Transforming growth factor-β1 inhibits prolactin secretion and lactotropic cell proliferation in the pituitary of estrogen-treated Fischer 344 rats. Neurochem Int 30:499-506
49. Sarkar DK, Kim KH, Minami S 1992 Transforming growth factor-β1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol Endocrinol 6:1825-1833
50. Hentges S, Boyadjieva N, Sarkar DK 2000 Transforming growth factor-β3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 141:859-867
51. Bermont L, Lamielle-Musard F, Chezy E, Weisz A, Adessi GL 2001 17β Estradiol inhibits forskolin induced vascular endothelial growth factor promoter in MCF-7 breast carcinoma cells. J Steroid Biochem Mol Biol 78:343-349
52. Cho H, Katzenellenbogen BS 1993 Synergistic activation of estrogen receptor mediated transcription by estradiol and protein kinase activators. Mol Endocrinol 7:441-452
53. Casibang M, Purdom S, Neckers L, Zia F, Ben-Av P, Hla T, You L, Jablons DM, Moody TW 2001 Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells. Lung Cancer 31:203-212
54. Burns G, Sarkar DK 1993 Transforming growth factor-β1-like immunoreactivity in the pituitary gland of the rat: Effect of estrogen. Endocrinology 133:1444-1449
55. Ferrara N, Henzel WJ 1989 Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858